Genmab — December 2017
-
-
-
God morgen.

-
Dr. Gasparetto on Results for Selinexor and Daratumumab in
Relapsed/Refractory Multiple Myeloma http://www.onclive.com/conference-coverage/ash-2017/dr-gasparetto-on-results-for-selinexor-and-daratumumab-in-relapsedrefractory-multiple-myeloma -
on the phase II trial of ofatumumab & bendamustine + bortezomib https://twitter.com/WCMCLymphoma/status/939990632755580928
-
a few enthusiastic tweets like this on daratumumab in relapsed AL Amyloidosis https://twitter.com/SurbhiSidana/status/939982402310623236
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind